Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1226 of 6351
-
Proton beam targets breast cancer with fewer side effects
Disease control OngoingThe purpose of this is to determine the efficacy and toxicity of proton therapy when used to deliver partial breast radiotherapy in patients with early stage breast cancer with low or intermediate risk factors.
Sponsor: Loma Linda University • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Could botox stop nerve pain before it becomes chronic?
Symptom relief CancelledBotulinum toxin type A has been reported to inhibit the release of various pain neurotransmitters (SP, CGRP, glutamate) responsible for neurogenic inflammation, a process that results from the sensitization of C-fiber nociceptors (peripheral sensitization). This action is probabl…
Phase 3 • Sponsor: University Hospital, Limoges • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
New combo therapy aims to boost lung cancer fight
Disease control OngoingThis clinical trial studies image-guided hypofractionated radiation therapy (RT) when given together with hypofractionated RT boost and combination chemotherapy in treating patients with stage II-III non-small cell lung cancer (NSCLC) that cannot be removed by surgery. RT uses hi…
Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Which radiotherapy technique offers best value for pelvic cancers?
Disease control CompletedThe aim of the study is a medico-economic evaluation to estimate a cost differential between three modalities of Intensity-Modulated Radiation Therapy for cancers of the prostate, cervix and anal canal with pelvic lymph node irradiation : treatment with helical Tomotherapy and dy…
Sponsor: Institut Cancerologie de l'Ouest • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Lupus kidney patients may be able to ditch heavy meds after two years
Disease control CompletedThe investigators wish to evaluate the discontinuation of maintenance immunosuppressive treatment after 2 years in patients with stable remission after a proliferative lupus nephritis. The patients will be continuing their treatment with hydroxychloroquine, possibly associated wi…
Phase 3 • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Disease control
Last updated Jun 26, 2026 18:09 UTC
-
New radiation technique may spare bowel in cervical cancer treatment
Disease control CompletedThe study tests Tomtherapy based Image Guided Radiation against conventional radiation techniques for it's ability to reduce long term small bowel toxicity.
Phase 3 • Sponsor: Tata Memorial Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Heat treatment may stop precancerous esophagus changes
Disease control CompletedRadiofrequency ablation versus endoscopic surveillance in the management of low grade dysplasia in Barrett oesophagus: a multicentric randomised controlled trial.
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 26, 2026 16:05 UTC
-
Brain zaps could silence voices that drugs Can't stop
Symptom relief Completed* The efficacy of neuro-navigated rTMS for patients with schizophrenia suffering from drug-resistant multisensory hallucinations will be tested by the implementation of a double-blind randomized controlled trial (RCT) * This study will use a combination of different MRI modalitie…
Sponsor: University Hospital, Lille • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Proton therapy showdown: 5 sessions vs. 44 for prostate cancer
Disease control OngoingThe purpose of this study is to compare the effects (good and bad) on patients with prostate cancer by comparing the standard dose of radiation therapy (44 treatments over 8½-9 weeks) with a higher daily dose of radiation (5 treatments over 1-2 weeks) to see if the effects of the…
Phase 3 • Sponsor: Proton Collaborative Group • Aim: Disease control
Last updated Jun 26, 2026 14:00 UTC
-
Proton beam zaps liver tumors: new hope for cancer patients?
Disease control CompletedStereotactic body radiation therapy (SBRT) is a technique that is used to deliver radiation, to sites in the body. All participants in this study will be treated with SBRT using proton beam radiation. Proton beam radiation uses tiny particles to deliver radiation to tumors. The p…
Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Placenta cells could tame Crohn's inflammation
Disease control CompletedThis Phase 2a study evaluated the efficacy, safety, and tolerability of intravenous human placenta-derived cells (PDA001) compared with placebo in adults with moderate-to-severe Crohn's disease. Three PDA001 dose levels were evaluated.
Phase 2 • Sponsor: Celularity Incorporated • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New drug cocktail aims to boost stem cell transplant success in myeloma
Disease control OngoingA) Phase 1: To determine the maximal tolerated dose (MTD) of lenalidomide that can be safely added to high-dose melphalan prior to autologous stem cell transplantation (ASCT). B) Phase 2: To determine whether the addition of high-dose lenalidomide to ASCT followed by maintenance…
Phase 1/2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Massive study tests if daily pills can ward off cancer and heart attacks
Prevention OngoingThe VITamin D and OmegA-3 TriaL (VITAL) is a randomized clinical trial in 25,871 U.S. men and women investigating whether taking daily dietary supplements of vitamin D3 (2000 IU) or omega-3 fatty acids (Omacor® fish oil, 1 gram) reduces the risk of developing cancer, heart diseas…
Phase 3 • Sponsor: Brigham and Women's Hospital • Aim: Prevention
Last updated Aug 01, 2026 00:00 UTC
-
Second stem cell transplant shows promise for returning myeloma
Disease control CompletedStudy for the outcome and safety of individualized busulfan dosing with bortezomib for patients preparing for a second stem cell transplant to treat multiple myeloma.
Phase 2 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Double-Dose transplant strategy shows promise for myeloma patients
Disease control CompletedHigh dose chemotherapy with stem cell transplantation is commonplace in the treatment of multiple myeloma. This treatment uses a chemotherapy drug called Melphalan that has been used in several thousand bone marrow transplant recipients worldwide for the same or similar disorders…
Phase 3 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 26, 2026 18:29 UTC
-
Blood test may guide chemo decisions for advanced breast cancer
Knowledge-focused CompletedEvaluation of the use of Circulating tumour Cells to guide chemotherapy from the 3rd line of chemotherapy for metastatic breast cancer.
Phase 3 • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Simple blood test could replace risky prenatal procedures for down syndrome
Diagnosis CompletedDemonstrate that the High output shotgun sequencing of the foetal DNA in the maternal blood could allow a complete discrimination between the mothers of a trisomic fetus 21 or a DISOMIQUE foetus 21 from the first quarter of the pregnancy, and so to obtain a reliable alternative i…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jun 27, 2026 08:11 UTC
-
Could a stem cell drug tame rare immune disease?
Disease control CompletedBackground: * WHIMS (Warts, Hypogammaglobulinemia, Infections, and Myelokathexis Syndrome) is caused by various genetic changes that increase the activity of the chemokine receptor, CXCR4. Excessive function of this receptor causes mature neutrophils (part of the white blood cel…
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 10, 2026 04:00 UTC
-
AI reads lung cancer scans to predict survival
Knowledge-focused CompletedThis study aims to evaluate the role of artificial intelligence (AI) in predicting disease stage and survival in patients diagnosed with non-small cell lung cancer (NSCLC). Using a retrospective design, the research will analyze radiologic imaging data (PET-CT and chest CT) and c…
Sponsor: Hilkat Fatih Elverdi • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
Could treating childhood depression be more effective when parents join the therapy?
Disease control CompletedThis study is designed to compare two treatments for depression in pre-adolescent (7-13 year old) children. A family-focused treatment will be compared to an individual child-focused treatment in this 14-week intervention.
Sponsor: Boston University Charles River Campus • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC